Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 19 studies | 23% ± 6% | |
CD16-positive, CD56-dim natural killer cell, human | 11 studies | 27% ± 12% | |
gamma-delta T cell | 5 studies | 16% ± 1% | |
CD8-positive, alpha-beta T cell | 4 studies | 24% ± 2% | |
mature NK T cell | 4 studies | 23% ± 5% | |
mucosal invariant T cell | 4 studies | 17% ± 2% | |
CD16-negative, CD56-bright natural killer cell, human | 4 studies | 30% ± 13% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 24% ± 7% |
Insufficient scRNA-seq data for expression of PLEKHF1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 100% | 1553.16 | 170 / 170 | 98% | 30.50 | 449 / 459 |
prostate | 100% | 1488.49 | 245 / 245 | 97% | 22.34 | 489 / 502 |
ovary | 98% | 661.60 | 176 / 180 | 99% | 45.27 | 425 / 430 |
skin | 99% | 720.45 | 1783 / 1809 | 97% | 18.90 | 458 / 472 |
bladder | 100% | 1445.86 | 21 / 21 | 94% | 43.26 | 472 / 504 |
lung | 99% | 892.07 | 573 / 578 | 93% | 19.95 | 1070 / 1155 |
esophagus | 100% | 1200.40 | 1443 / 1445 | 92% | 18.72 | 168 / 183 |
breast | 100% | 1502.25 | 459 / 459 | 90% | 16.76 | 1002 / 1118 |
liver | 98% | 716.28 | 222 / 226 | 90% | 19.69 | 367 / 406 |
intestine | 98% | 759.70 | 947 / 966 | 87% | 11.70 | 460 / 527 |
thymus | 96% | 578.27 | 629 / 653 | 79% | 11.62 | 475 / 605 |
stomach | 80% | 495.71 | 287 / 359 | 90% | 14.06 | 256 / 286 |
kidney | 76% | 343.47 | 68 / 89 | 87% | 9.49 | 782 / 901 |
brain | 74% | 299.56 | 1952 / 2642 | 88% | 11.44 | 621 / 705 |
pancreas | 54% | 175.87 | 178 / 328 | 95% | 19.78 | 169 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 29.76 | 29 / 29 |
spleen | 100% | 1196.60 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 1276.96 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1157.14 | 1331 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 3697.86 | 799 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1319.14 | 842 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 69% | 257.11 | 178 / 258 | 28% | 2.71 | 65 / 230 |
tonsil | 0% | 0 | 0 / 0 | 96% | 26.31 | 43 / 45 |
eye | 0% | 0 | 0 / 0 | 88% | 9.10 | 70 / 80 |
peripheral blood | 83% | 828.58 | 774 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_2001244 | Biological process | positive regulation of intrinsic apoptotic signaling pathway |
GO_0016050 | Biological process | vesicle organization |
GO_0008333 | Biological process | endosome to lysosome transport |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_0007032 | Biological process | endosome organization |
GO_0006915 | Biological process | apoptotic process |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005769 | Cellular component | early endosome |
GO_0005764 | Cellular component | lysosome |
GO_0010008 | Cellular component | endosome membrane |
GO_0005768 | Cellular component | endosome |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005634 | Cellular component | nucleus |
GO_0070273 | Molecular function | phosphatidylinositol-4-phosphate binding |
GO_0035091 | Molecular function | phosphatidylinositol binding |
GO_0032266 | Molecular function | phosphatidylinositol-3-phosphate binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0010314 | Molecular function | phosphatidylinositol-5-phosphate binding |
Gene name | PLEKHF1 |
Protein name | Pleckstrin homology domain-containing family F member 1 (PH domain-containing family F member 1) (Lysosome-associated apoptosis-inducing protein containing PH and FYVE domains) (Apoptosis-inducing protein) (PH and FYVE domain-containing protein 1) (Phafin-1) (Zinc finger FYVE domain-containing protein 15) Pleckstrin homology and FYVE domain containing 1 |
Synonyms | APPD LAPF ZFYVE15 |
Description | FUNCTION: May induce apoptosis through the lysosomal-mitochondrial pathway. Translocates to the lysosome initiating the permeabilization of lysosomal membrane (LMP) and resulting in the release of CTSD and CTSL to the cytoplasm. Triggers the caspase-independent apoptosis by altering mitochondrial membrane permeabilization (MMP) resulting in the release of PDCD8. . |
Accessions | K7ELB8 ENST00000588833.1 ENST00000436066.4 K7EIX0 ENST00000592810.1 Q96S99 ENST00000586888.1 |